Latest immunotherapy news
FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma
posted December 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Timing of Immune Checkpoint Inhibitor Administration Affects Small Cell Lung Cancer Survival
posted December 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rocatinlimab Yields Significant Improvements in Atopic Dermatitis
posted December 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
